K. Adamczuk, A. S. De-weer, N. Nelissen, P. Dupont, S. Sunaert et al., Functional changes in the language network in response to increased amyloid beta deposition in cognitively intact older adults, Cereb. Cortex, vol.26, pp.358-373, 2016.

K. Adamczuk, J. Schaeverbeke, N. Nelissen, V. Neyens, M. Vandenbulcke et al., Amyloid imaging in cognitively normal older adults: comparison between (18)F-flutemetamol and (11)C-Pittsburgh compound B, Eur. J. Nucl. Med. Mol. Imaging, vol.43, pp.142-151, 2016.

K. Adamczuk, J. Schaeverbeke, H. M. Vanderstichele, J. Lilja, N. Nelissen et al., Diagnostic value of cerebrospinal fluid Abeta ratios in preclinical Alzheimer's disease, Alzheimers Res. Ther, vol.7, p.75, 2015.

D. Alcolea, M. Carmona-iragui, M. Suarez-calvet, M. B. Sanchez-saudinos, I. Sala et al., Relationship between beta-Secretase, inflammation and core cerebrospinal fluid biomarkers for Alzheimer's disease, J. Alzheimers Dis, vol.42, pp.157-167, 2014.

, Diagnostic and Statistical Manual of Mental Disorders: DSM-IV, APA, 1994.

J. E. Baker, Y. Y. Lim, R. H. Pietrzak, J. Hassenstab, P. J. Snyder et al., Cognitive impairment and decline in cognitively normal older adults with high amyloid-?: a meta-analysis, Alzheimers Dement, vol.6, pp.108-121, 2017.

R. J. Bateman, C. Xiong, T. L. Benzinger, A. M. Fagan, A. Goate et al., Clinical and biomarker changes in dominantly inherited Alzheimer's disease, N. Engl. J. Med, vol.367, pp.795-804, 2012.

I. Bos, S. J. Vos, L. Frölich, J. Kornhuber, J. Wiltfang et al., The frequency and influence of dementia risk factors in prodromal Alzheimer's disease, Neurobiol. Aging, vol.56, pp.33-40, 2017.

M. R. Brier, B. Gordon, K. Friedrichsen, J. Mccarthy, A. Stern et al., Tau and Abeta imaging, CSF measures, and cognition in Alzheimer's disease, Sci. Transl. Med, vol.8, pp.338-366, 2016.

C. Cerami, A. Dodich, S. Iannaccone, G. Magnani, R. Santangelo et al., A biomarker study in long-lasting amnestic mild cognitive impairment, Alzheimers Res. Ther, vol.10, p.42, 2018.

M. Degerman-gunnarsson, M. Ingelsson, K. Blennow, H. Basun, L. Lannfelt et al., High tau levels in cerebrospinal fluid predict nursing home placement and rapid progression in Alzheimer's disease, Alzheimers Res. Ther, vol.8, p.22, 2016.

M. Demuru, A. A. Gouw, A. Hillebrand, C. J. Stam, B. W. Van-dijk et al., Functional and effective whole brain connectivity using magnetoencephalography to identify monozygotic twin pairs, Sci. Rep, vol.7, p.9685, 2017.

B. Dubois, H. Hampel, H. H. Feldman, P. Scheltens, P. Aisen et al., Preclinical Alzheimer's disease: definition, natural history, and diagnostic criteria, Alzheimers Dement, vol.12, pp.292-323, 2016.

J. Dumurgier, B. J. Hanseeuw, F. B. Hatling, K. A. Judge, A. P. Schultz et al., Alzheimer's disease biomarkers and future decline in cognitive normal older adults, J. Alzheimers Dis, vol.60, pp.1451-1459, 2017.

A. Estanga, M. Ecay-torres, A. Ibanez, A. Izagirre, J. Villanua et al., Beneficial effect of bilingualism on Alzheimer's disease CSF biomarkers and cognition, Neurobiol. Aging, vol.50, pp.144-151, 2017.

M. F. Folstein, S. E. Folstein, and P. R. Mchugh, Mini-mental state." a practical method for grading the cognitive state of patients for the clinician, J. Psychiatr. Res, vol.12, pp.189-198, 1975.

J. Fortea, R. Sala-llonch, D. Bartres-faz, B. Bosch, A. Llado et al., Increased cortical thickness and caudate volume precede atrophy in PSEN1 mutation carriers, J. Alzheimers Dis, vol.22, pp.909-922, 2010.

C. Franceschi and J. Campisi, Chronic inflammation (inflammaging) and its potential contribution to age-associated diseases, J. Gerontol. A Biol. Sci. Med. Sci, vol.69, pp.4-9, 2014.

B. Giunta, F. Fernandez, W. V. Nikolic, D. Obregon, E. Rrapo et al., Inflammaging as a prodrome to Alzheimer's disease, J. Neuroinflammation, vol.5, p.51, 2008.

J. Hassenstab, R. Chasse, P. Grabow, T. L. Benzinger, A. M. Fagan et al., Certified normal: Alzheimer's disease biomarkers and normative estimates of cognitive functioning, Neurobiol. Aging, vol.43, pp.23-33, 2016.

T. Hedden, H. Oh, A. P. Younger, and T. A. Patel, Meta-analysis of amyloid-cognition relations in cognitively normal older adults, Neurology, vol.80, pp.1341-1348, 2013.

C. R. Jack, D. S. Knopman, W. J. Jagust, R. C. Petersen, M. W. Weiner et al., Tracking pathophysiological processes in Alzheimer's disease: an updated hypothetical model of dynamic biomarkers, Lancet Neurol, vol.12, pp.207-216, 2013.

W. J. Jansen, R. Ossenkoppele, D. L. Knol, B. M. Tijms, P. Scheltens et al., Prevalence of cerebral amyloid pathology in persons without dementia: a meta-analysis, JAMA, vol.313, pp.1924-1938, 2015.

W. J. Jansen, R. Ossenkoppele, B. M. Tijms, A. M. Fagan, O. Hansson et al., Association of cerebral amyloid-beta aggregation with cognitive functioning in persons without dementia, JAMA Psychiatry, vol.75, pp.84-95, 2017.

L. Joie, R. Landeau, B. Perrotin, A. Bejanin, A. Egret et al., Intrinsic connectivity identifies the hippocampus as a main crossroad between Alzheimer's and semantic dementia-targeted networks, Neuron, vol.81, pp.1417-1428, 2014.

M. D. Lezak, D. B. Howieson, and D. W. Loring, Neuropsychological Assessment, 2004.

Y. Y. Lim, S. M. Laws, V. L. Villemagne, R. H. Pietrzak, T. Porter et al., Abeta-related memory decline in APOE epsilon4 noncarriers: implications for Alzheimer disease, Neurology, vol.86, pp.1635-1642, 2016.

I. G. Mckeith, D. Galasko, K. Kosaka, E. K. Perry, D. W. Dickson et al., Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): report of the consortium on DLB international workshop, vol.47, pp.1113-1124, 1996.

G. Mckhann, D. Drachman, M. Folstein, R. Katzman, D. Price et al., Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of department of health and human services task force on Alzheimer's Disease, Neurology, vol.34, pp.939-944, 1984.

M. M. Mielke, M. M. Machulda, C. E. Hagen, T. J. Christianson, R. O. Roberts et al., Influence of amyloid and APOE on cognitive performance in a late middle-aged cohort, Alzheimers Dement, vol.12, pp.281-291, 2016.

E. C. Mormino, R. A. Betensky, T. Hedden, A. P. Schultz, R. E. Amariglio et al., Synergistic effect of beta-amyloid and neurodegeneration on cognitive decline in clinically normal individuals, JAMA Neurol, vol.71, pp.1379-1385, 2014.

S. G. Mueller, M. W. Weiner, L. J. Thal, R. C. Petersen, C. R. Jack et al., Ways toward an early diagnosis in Alzheimer's disease: the Alzheimer's Disease Neuroimaging Initiative (ADNI), Alzheimers Dement, vol.1, pp.55-66, 2005.

D. Neary, J. S. Snowden, L. Gustafson, U. Passant, D. Stuss et al., Frontotemporal lobar degeneration: a consensus on clinical diagnostic criteria, Neurology, vol.51, pp.1546-1554, 1998.

P. T. Nelson, I. Alafuzoff, E. H. Bigio, C. Bouras, H. Braak et al., Correlation of Alzheimer disease neuropathologic changes with cognitive status: a review of the literature, J. Neuropathol. Exp. Neurol, vol.71, pp.362-381, 2012.

H. Oh, C. Madison, T. J. Haight, C. Markley, and W. J. Jagust, Effects of age and beta-amyloid on cognitive changes in normal elderly people, Neurobiol. Aging, vol.33, pp.2746-2755, 2012.

R. C. Petersen, H. J. Wiste, S. D. Weigand, W. A. Rocca, R. O. Roberts et al., Association of elevated amyloid levels with cognition and biomarkers in cognitively normal people from the community, JAMA Neurol, vol.73, pp.85-92, 2016.

C. Pettigrew, A. Soldan, A. Moghekar, M. C. Wang, A. L. Gross et al., Relationship between cerebrospinal fluid biomarkers of Alzheimer's disease and cognition in cognitively normal older adults, Neuropsychologia, vol.78, pp.63-72, 2015.

B. L. Reijs, I. Ramakers, L. Elias-sonnenschein, C. E. Teunissen, M. Koel-simmelink et al., Relation of odor identification with Alzheimer's disease markers in cerebrospinal fluid and cognition, J. Alzheimers Dis, vol.60, pp.1025-1034, 2017.

R. Reitan, Trail-Making Test, 1979.

A. Rey, L'examen Clinique en Psychologie, 1958.

G. C. Roman, T. K. Tatemichi, T. Erkinjuntti, J. L. Cummings, J. C. Masdeu et al., Vascular dementia: diagnostic criteria for research studies. report of the NINDS-AIREN international workshop, vol.43, pp.250-260, 1993.

I. Sala, I. Illan-gala, D. Alcolea, M. B. Sanchez-saudinos, S. A. Salgado et al., Diagnostic and prognostic value of the combination of two measures of verbal memory in mild cognitive impairment due to Alzheimer's disease, J. Alzheimers Dis, vol.58, pp.909-918, 2017.

B. Schmand, P. Houx, and I. Koning, Norms for Stroop Color Word Test, Trail Making Test, and Story Recall of Rivermead Behavioural Memory Test, 2003.

A. A. Simen, K. A. Bordner, M. P. Martin, L. A. Moy, and L. C. Barry, , 2011.

, Cognitive dysfunction with aging and the role of inflammation, Ther. Adv. Chronic Dis, vol.2, pp.175-195

W. Van-der-elst, M. P. Van-boxtel, G. J. Van-breukelen, J. , and J. , , 2005.

, Rey's verbal learning test: normative data for 1855 healthy participants aged 24-81 years and the influence of age, sex, education, and mode of presentation, J. Int. Neuropsychol. Soc, vol.11, pp.290-302

W. Van-der-elst, M. P. Van-boxtel, G. J. Van-breukelen, J. , and J. , Normative data for the animal, profession and letter m naming verbal fluency tests for dutch speaking participants and the effects of age, education, and sex, J. Int. Neuropsychol. Soc, vol.12, pp.80-89, 2006.

P. Vemuri and D. S. Knopman, The role of cerebrovascular disease when there is concomitant Alzheimer disease, Biochim. Biophys. Acta, vol.1862, pp.952-956, 2016.

P. J. Visser, A. Kester, J. Jolles, and F. Verhey, Ten-year risk of dementia in subjects with mild cognitive impairment, Neurology, vol.67, pp.1201-1207, 2006.

S. J. Vos, F. Verhey, L. Frolich, J. Kornhuber, J. Wiltfang et al., Prevalence and prognosis of Alzheimer's disease at the mild cognitive impairment stage, Brain, vol.138, pp.1327-1338, 2015.

S. J. Vos, C. Xiong, P. J. Visser, M. S. Jasielec, J. Hassenstab et al., Preclinical Alzheimer's disease and its outcome: a longitudinal cohort study, Lancet Neurol, vol.12, issue.13, pp.70194-70201, 2013.

A. Wallin, A. Nordlund, M. Jonsson, K. Blennow, H. Zetterberg et al., Alzheimer's disease-subcortical vascular disease spectrum in a hospital-based setting: overview of results from the Gothenburg MCI and dementia studies, J. Cereb. Blood Flow. Metab, vol.36, pp.95-113, 2016.